Transdermal Delivery of Peptides and Proteins

Peptide and Protein Delivery

Volumn , Issue , 2011, Pages 69-86

  Herwadkar, Anushree ^a   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873081687     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384935-9.10004-5     Document Type: Chapter

References (53)

1. A.C. Williams (1993) Transdermal and Topical Drug Delivery from Theory to Clinical Practice. London, UK: Pharmaceutical Press pp. 1–14
2. A.K. Banga (1998) Electrically Assisted Transdermal and Topical Drug Delivery. London, UK: Taylor & Francis pp. 2–4
3. K.A. Walters and M.S. Roberts (2007) The structure and function of skin. K.A. Walters (Ed.) Dermatological and Transdermal Formulations New York: Informa Healthcare USA Inc. 1-41.
4. R. Alvarez-Roman, A. Naik, Y.N. Kalia, R.H. Guy and H. Fessi (2004) Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 99 53-62.
5. C. Cullander and R.H. Guy (1991) Sites of Iontophoretic current flow into the skin: Identification and characterization with the vibrating probe electrode. J. Invest. Dermatol. 97 55-64.
6. H.K. Choi, G.L. Flynn and G.L. Amidon (1990) Transdermal delivery of bioactive peptides: The effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport. Pharm. Res. 7 1099-1106.
7. W.R. Lee, T.L. Pan, P.W. Wang, R.Z. Zhuo, C.M. Huang and J.Y. Fang (2008) Erbium-YAG laser enhances transdermal peptide delivery and skin vaccination. J. Control. Release 128 200-208.
8. A. Naik, Y.N. Kalia and R.H. Guy (2000) Transdermal drug delivery: Overcoming the skins barrier function. Pharmaceut. Sci. Tech. Today 3 318-326.
9. H.A. Benson (2005) Transdermal Drug Delivery: Penetration Enhancement Techniques. Curr. Drug Deliv. 2 23-33.
10. H.A. Benson and S. Namjoshi (2008) Proteins and peptides: Strategies for delivery to and across skin. J. Pharm. Sci. 97 3591-3610.
11. A.K. Banga (2006) Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems. 2nd Ed. Boca Raton, USA: CRC Press, Taylor and Francis Group
12. G.M. El Maghraby, B.W. Barry and A.C. Williams (2008) Liposomes and skin: From drug delivery to model membranes. Eur. J. Pharm. Sci. 34 203-232.
13. M. Foldvari, M.E. Baca-Estrada, Z. He, J. Hu, S. Attah-Poku and M. King (1999) Dermal and transdermal delivery of protein pharmaceuticals: Lipid-based delivery systems for interferon alpha. Biotechnol. Appl. Biochem. 30 129-137.
14. G. Cevc, D. Gebauer, J. Stieber, A. Schätzlein and G. Blume (1998) Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368 201-215.
15. S. Muranishi, A. Sakai, K. Yamada, M. Murakami, K. Takada and Y. Kiso (1991) Lipophilic peptides: Synthesis of lauroyl thyrotropin-releasing hormone and its biological activity. Pharm. Res. 8 649-652.
16. M. Hashimoto, K. Takada, Y. Kiso and S. Muranishi (1989) Synthesis of palmitoyl derivatives of insulin and their biological activities. Pharm. Res. 6 171-176.
17. Y.B. Schuetz, A. Naik, R.H. Guy and Y.N. Kalia (2005) Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin. Drug Deliv. 2 533-548.
18. O. Pillai and R. Panchagnula (2003) Transdermal delivery of insulin from poloxamer gel: Ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J. Control. Release 89 127-140.
19. B.M. Magnusson and P. Runn (1999) Effect of penetration enhancers on the permeation of the thyrotropin releasing hormone analogue pGlu-3-methyl-His-Pro amide through human epidermis. Int. J. Pharm. 178 149-159.
20. A.K. Banga (2009) Microporation applications for enhancing drug delivery. Expert Opin. Drug Deliv. 6 343-354.
21. R.K. Sivamani, D. Liepmann and H.I. Maibach (2007) Microneedles and transdermal applications. Expert Opin. Drug Deliv. 4 19-25.
22. S. Henry, D.V. McAllister, M.G. Allen and M.R. Prausnitz (2000) Microfabricated microneedles: A novel approach to transdermal drug delivery. J. Pharm. Sci. 87 922-925.
23. F.J. Verbaan, S.M. Bal, D.J. van den Berg, W.H. Groenink, H. Verpoorten, R. Luttge, et al. (2007) Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control. Release 117 238-245.
24. H.S. Gill and M.R. Prausnitz (2007) Coated microneedles for transdermal delivery. J. Control. Release 117 227-237.
25. G. Li, A. Badkar, S. Nema, C.S. Kolli and A.K. Banga (2009) In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int. J. Pharm. 368 109-115.
26. A.V. Badkar, A.M. Smith, J.A. Eppstein and A.K. Banga (2007) Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm. Res. 24 1389-1395.
27. M. Cormier, B. Johnson, M. Ameri, K. Nyam, L. Libiran, D.D. Zhang, et al. (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97 503-511.
28. X. Chen, T.W. Prow, M.L. Crichton, D.W. Jenkins, M.S. Roberts, I.H. Frazer, et al. (2009) Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J. Control. Release 139 212-220.
29. P.G. Green (1996) Iontophoretic delivery of peptide drugs. J. Control. Release 41 33-48.
30. A.K. Banga (2007) Theme section: Transdermal delivery of proteins. Pharm. Res. 24 1357-1359.
31. R.H. Guy, Y.N. Kalia, M.B. Delgado-Charro, V. Merino, A. Lopez and D. Marro (2000) Iontophoresis: Electrorepulsion and electro-osmosis. J. Control. Release 64 129-132.
32. R. Panchagnula, O. Pillai, V.B. Nair and P. Ramarao (2000) Transdermal iontophoresis revisited. Curr. Opin. Chem. Biol. 4 468-473.
33. O. Pillai, S.D. Borkute, N. Sivaprasad and R. Panchagnula (2003) Transdermal iontophoresis of insulin. II. Physicochemical considerations. Int. J. Pharm. 254 271-280.
34. N. Kanikkannan, J. Singh and P. Ramarao (1999) Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. J. Control. Release 59 99-105.
35. S.L. Chang, G.A. Hofmann, L. Zhang, L.J. Deftos and A.K. Banga (2000) Transdermal iontophoretic delivery of salmon calcitonin. Int. J. Pharm. 200 107-113.
36. A. Chaturvedula, D.P. Joshi, C. Anderson, R.L. Morris, W.L. Sembrowich and A.K. Banga (2005) In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. Int. J. Pharm. 297 190-196.
37. R.R. Boinpally, S.L. Zhou, G. Devraj, P.K. Anne, S. Poondru and B.R. Jasti (2004) Iontophoresis of lecithin vesicles of cyclosporin A. Int. J. Pharm. 274 185-190.
38. B. Vinod and R.P. Nair (2003) Effects of iontophoresis and fatty acids on permeation of Arginine Vasopressin through rat skin. Pharmacol. Res. 47 563-569.
39. M.B. Delgadocharro, A.M. Rodriguezbayon and R.H. Guy (1995) Iontophoresis of nafarelin: Effects of current density and concentration on electrotransport in vitro. J. Control. Release 35 35-40.
40. J. Raiman, M. Koljonen, K. Huikko, R. Kostiainen and J. Hirvonen (2004) Delivery and stability of LHRH and Nafarelin in human skin: The effect of constant/pulsed iontophoresis. Eur. J. Pharm. Sci. 21 371-377.
41. A. Jadoul, C. Hanchard, S. Thysman and V. Preat (1995) Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int. J. Pharm. 120 221-228.
42. S. Katikaneni, G. Li, A. Badkar and A.K. Banga (2010) Transdermal delivery of a ~13 kDa protein – an in vivo comparison of physical enhancement methods. J. Drug Target. 18 141-147.
43. S. Mitragotri, D. Blankschtein and R. Langer (1995) Ultrasound-mediated transdermal protein delivery. Science 269 850-853.
44. S. Mitragotri and J. Kost (2004) Low-frequency sonophoresis: A review. Adv. Drug Deliv. Rev. 56 569-601.
45. N.B. Smith (2007) Perspectives on transdermal ultrasound mediated drug delivery. Int. J. Nanomedicine 2 585-594.
46. A. Tezel and S. Mitragotri (2003) Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys. J. 85 3502-3512.
47. K.Y. Ng (2004) Enhancing transdermal drug transport with low-frequency ultrasound. Drug Discov. Today 9 913.
48. L. Machet and A. Boucaud (2002) Phonophoresis: Efficiency, mechanisms and skin tolerance. Int. J. Pharm. 243 1-15.
49. L.J. Weimann and J. Wu (2002) Transdermal delivery of poly-l-lysine by sonomacroporation. Ultrasound Med. Biol. 28 1173-1180.
50. S. Mitragotri and J. Kost (2001) Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm. Res. 18 1151-1156.
51. N.B. Smith, S. Lee and K.K. Shung (2003) Ultrasound-mediated transdermal in vivo transport of insulin with low-profile cymbal arrays. Ultrasound Med. Biol. 29 1205-1210.
52. A.K. Banga and M.R. Prausnitz (1998) Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Trends Biotechnol. 16 408-412.
53. J.E. Riviere, N.A. Monteiroriviere, R.A. Rogers, D. Bommannan, J.A. Tamada and R.O. Potts (1995) Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and skin toxicology. J. Control. Release 36 229-233.